Cargando…

lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma

Cervical cancer (CC) remains one of the leading causes of mortality of female cancers worldwide, with more than 90% being cervical squamous cell carcinoma (CSCC). ΔNp63α is the predominant isoform expressed in cervical epithelial tissues and exerts its antitumor function in CSCC. In this study, we h...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hanyuan, Zhu, Chenchen, Xu, Zhihao, Wang, Juan, Qian, Lili, Zhou, Qingqing, Shen, Zhen, Zhao, Weidong, Xiao, Weihua, Chen, Liang, Zhou, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648017/
https://www.ncbi.nlm.nih.gov/pubmed/32920922
http://dx.doi.org/10.1111/cas.14649
_version_ 1783607027419840512
author Liu, Hanyuan
Zhu, Chenchen
Xu, Zhihao
Wang, Juan
Qian, Lili
Zhou, Qingqing
Shen, Zhen
Zhao, Weidong
Xiao, Weihua
Chen, Liang
Zhou, Ying
author_facet Liu, Hanyuan
Zhu, Chenchen
Xu, Zhihao
Wang, Juan
Qian, Lili
Zhou, Qingqing
Shen, Zhen
Zhao, Weidong
Xiao, Weihua
Chen, Liang
Zhou, Ying
author_sort Liu, Hanyuan
collection PubMed
description Cervical cancer (CC) remains one of the leading causes of mortality of female cancers worldwide, with more than 90% being cervical squamous cell carcinoma (CSCC). ΔNp63α is the predominant isoform expressed in cervical epithelial tissues and exerts its antitumor function in CSCC. In this study, we have identified 39 long noncoding RNAs as ΔNp63α targets in CSCC through RNA sequencing and chromatin immunoprecipitation sequencing, in which we further confirmed and focused on the two tumor‐related long noncoding RNAs, PART1 (lncPART1) and MIR17HG (lncMIR17HG). Experiments from stable overexpression/knockdown cell lines revealed that lncPART1 and lncMIR17HG regulated cell proliferation, migration, and invasion. In vivo experiments further showed that lncPART1 suppresses tumor growth in CSCC‐derived tumors. Examinations of clinical tissues indicated that the expression of lncPART1 was positively correlated with ΔNp63α expression, while lncMIR17HG was negatively correlated with ΔNp63α expression, suggesting that ΔNp63α plays a central role via regulating its direct targets in the progression of CSCC. These findings provide novel insights in targeted therapy of cervical cancers.
format Online
Article
Text
id pubmed-7648017
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-76480172020-11-16 lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma Liu, Hanyuan Zhu, Chenchen Xu, Zhihao Wang, Juan Qian, Lili Zhou, Qingqing Shen, Zhen Zhao, Weidong Xiao, Weihua Chen, Liang Zhou, Ying Cancer Sci Original Articles Cervical cancer (CC) remains one of the leading causes of mortality of female cancers worldwide, with more than 90% being cervical squamous cell carcinoma (CSCC). ΔNp63α is the predominant isoform expressed in cervical epithelial tissues and exerts its antitumor function in CSCC. In this study, we have identified 39 long noncoding RNAs as ΔNp63α targets in CSCC through RNA sequencing and chromatin immunoprecipitation sequencing, in which we further confirmed and focused on the two tumor‐related long noncoding RNAs, PART1 (lncPART1) and MIR17HG (lncMIR17HG). Experiments from stable overexpression/knockdown cell lines revealed that lncPART1 and lncMIR17HG regulated cell proliferation, migration, and invasion. In vivo experiments further showed that lncPART1 suppresses tumor growth in CSCC‐derived tumors. Examinations of clinical tissues indicated that the expression of lncPART1 was positively correlated with ΔNp63α expression, while lncMIR17HG was negatively correlated with ΔNp63α expression, suggesting that ΔNp63α plays a central role via regulating its direct targets in the progression of CSCC. These findings provide novel insights in targeted therapy of cervical cancers. John Wiley and Sons Inc. 2020-09-29 2020-11 /pmc/articles/PMC7648017/ /pubmed/32920922 http://dx.doi.org/10.1111/cas.14649 Text en © 2020 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Liu, Hanyuan
Zhu, Chenchen
Xu, Zhihao
Wang, Juan
Qian, Lili
Zhou, Qingqing
Shen, Zhen
Zhao, Weidong
Xiao, Weihua
Chen, Liang
Zhou, Ying
lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
title lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
title_full lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
title_fullStr lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
title_full_unstemmed lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
title_short lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
title_sort lncrna part1 and mir17hg as δnp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648017/
https://www.ncbi.nlm.nih.gov/pubmed/32920922
http://dx.doi.org/10.1111/cas.14649
work_keys_str_mv AT liuhanyuan lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT zhuchenchen lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT xuzhihao lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT wangjuan lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT qianlili lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT zhouqingqing lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT shenzhen lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT zhaoweidong lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT xiaoweihua lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT chenliang lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma
AT zhouying lncrnapart1andmir17hgasdnp63adirecttargetsregulatetumorprogressionofcervicalsquamouscellcarcinoma